Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Operating Expenses | 578 | 799 | 277 | 0 | 96 |
| Operating Income | -578 | -799 | -277 | N/A | -96 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Pre-tax Income | -578 | -799 | -277 | 0 | -97 |
| Net Income Continuous | -578 | -799 | -277 | N/A | -97 |
| Net Income | $-578 | $-799 | $-277 | $N/A | $-97 |
| EPS Basic Total Ops | -97.14 | -18.89 | -5.40 | N/A | -2.70 |
| EPS Basic Continuous Ops | -97.91 | -18.45 | -6.59 | N/A | -2.96 |
| EPS Diluted Total Ops | -97.14 | -18.89 | -5.40 | N/A | -2.70 |
| EPS Diluted Continuous Ops | -97.91 | -18.45 | -6.59 | N/A | -2.96 |
| EBITDA(a) | $-578 | $-798 | $-277 | $N/A | $-96 |